@article{JTD23082,
author = {Yanis Boumber},
title = {Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {8},
year = {2018},
keywords = {},
abstract = {Tumors avoid immune surveillance by inactivating various T-cell cytotoxic pathways that can promote cell death (1-3). Cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death 1 (PD-1) are expressed primarily on cytotoxic T lymphocytes. In contrast, programmed death ligand 1 (PD-L1) is expressed on antigen-presenting lymphoid and non-lymphoid tissues, on tumor cells, and on virus-infected cells.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/23082}
}